-
Jul 16, 2015, 11:10 AM
by
Michael Croft
Bio-IT World | After receiving FDA clearance for a single carrier screening test this February, 23andMe has promised to release a new health product to its customers later this year. But regulations are sure to change the types of genetic tests available on the direct-to-consumer market — and lead some to look for alternative ways to expand public access to useful genomic information.
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
CHORLEY, UNITED KINGDOM - Jul 15, 2015 - Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centres in Eastern Europe and a total network of 25 across Europe and Africa
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
HARDERWIJK, NETHERLANDS - Jul 15, 2015 - Today, molecular
genetics Ag Biotech company KeyGene and biomedical big data
solutions company GENALICE, jointly mark the significant mutual
benefits of their first two years of partnerships, running GENALICE
MAP in full production as their preferred tool for primary
Next-Generation Sequencing (NGS) data analysis
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
LUND, SWEDEN - Jul 15, 2015 - ~~Qlucore announces 3 year
license from Europe's largest biopharmaceutical company
Software to help Actelion visualize and analyze "big data"
Qlucore, a world leader in the development of bioinformatics
software, has announced a three year license contract with
Actelion, one of Europe's leading biopharmaceutical companies
Full story
-
Jul 15, 2015, 00:00 AM
by
Michael Croft
Forbes | Matthew Herper talks to Elizabeth Holmes
and the organizations partnering with her company Theranos, to
check out the evidence for her claims to radically reduce the price
and burden of blood tests.
Full story
-
Jul 14, 2015, 15:00 PM
by
Michael Croft
Bio-IT World News Brief | The Paul G. Allen Family Foundation announced five Allen Distinguished Investigator (ADI) grants to teams of researchers with projects that will open new and innovative avenues of research in Alzheimer’s disease. The projects are funded at a total of $7 million over three years.
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
ROCHESTER, NY, UNITED STATES - Jul 14, 2015 - The latest iteration of Clinical Conductor CTMScontinues the proven strategy of providing research organizations with the most in-depth features and functionality available, further distancing the application from others in the industry, which fail to provide the tools necessary for truly complete clinical research management
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
SAN DIEGO, CA, UNITED STATES - Jul 14, 2015 - Rancho BioSciences, the Data Curation Company, today announced that they will work with BT to provide cloud-based data curation services to their joint customers
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
CNET | Two supercomputing centers of excellence
revolve around making sure applications can take advantage of
compute horsepower and gathering feedback from developers,
engineers and scientists.
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
GeekWire | Lee Hood's new startup, Arivale, raised
$36 million yesterday from Arch Venture Partners and Polaris
Partners. The company's total funding is now at $40 million.
Full story
-
Jul 14, 2015, 00:00 AM
by
Michael Croft
LENEXA, KS, UNITED STATES - Jul 14, 2015 - Contract Research Organization XenoTech, LLC, a division of Sekisui, announces the addition of in vitro toxicology to its global drug development service portfolio
Full story
-
Jul 10, 2015, 00:00 AM
by
Michael Croft
Xconomy | The U.S. House of Representatives took a
big step this morning toward major changes in the federal
government's relationship to biomedical research, funding and
regulation.
Full story
-
Jul 10, 2015, 00:00 AM
by
Michael Croft
Xconomy | Biogen's top research and development
executive Doug Williams is leaving the company this month to take
the helm at a startup that doesn't yet have a name.
Full story
-
Jul 10, 2015, 00:00 AM
by
Michael Croft
Xconomy | Juno Therapeutics has built remarkable
momentum and is about to launch the first trial in humans of
engineered T cells.
Full story
-
Jul 9, 2015, 11:00 AM
by
Michael Croft
Bio-IT World | The Pistoia Alliance has launched a business plan contest that will ask startup companies from around the world to develop new ideas to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 invites small and medium enterprises to compete for cash prizes and expert mentorship from a senior industry figure drawn from the Pistoia Alliance membership.
Full story
-
Jul 9, 2015, 00:00 AM
by
Michael Croft
EDINBURGH, UNITED KINGDOM - Jul 9, 2015 - Aridhia, the pioneering clinical and translational informatics company, today announced a revolutionary mini-app rapid development solution specifically for clinical applications
Full story
-
Jul 8, 2015, 00:00 AM
by
Michael Croft
Washington Post | Scientists say genomics will end
up being the biggest data hog, set to surpass astronomy, particle
physics -- even YouTube.
Full story
-
Jul 8, 2015, 00:00 AM
by
Michael Croft
Forbes | GlaxoSmithKline is investing $95 million
in a nonprofit research center in Seattle called the Altius
Institute for Biomedical Sciences, focusing on the "dark matter" of
the genome.
Full story
-
Jul 7, 2015, 09:50 AM
by
Michael Croft
Bio-IT World | Following on studies like ClinSeq and MedSeq, Mount Sinai School of Medicine's HealthSeq project is tracking patient responses to genome-wide testing, in an effort to extend these studies to a more diverse population and include non-health-related results like ancestry and physical trait information.
Full story
-
Jul 7, 2015, 00:00 AM
by
Michael Croft
SAN MATEO, CA - Jul 7, 2015 - Maverix Biomics, Inc. today announced that EDGC (the Eone-Diagnomics Genome Center), a joint venture between an affiliate of the Eone Life Science Institute and Diagnomics, signed a contract to be the initial diagnostic testing customer on the Maverix Dx Platform
Full story